Bioceres Crop Solutions vs CF Industries
BIOX and CF side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BIOX and CF compare
CF Industries grew revenue faster over the last twelve months (17.9% versus −17.7% for Bioceres Crop Solutions).
CF Industries pays a dividend yielding 1.7%; Bioceres Crop Solutions does not pay one.
CF Industries scores higher on the StockData Score (17 against 1 for Bioceres Crop Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BIOX | CF |
|---|---|---|
| Size and price | ||
| Market cap | – | $18.7B |
| Share price | $0.233 | $123.24 |
| Change, 1 year | −86.6% | 48.8% |
| Change, 5 years | −98.5% | 89.0% |
| Beta (5Y) | 0.76 | 0.15 |
| Employees | 562 | 2,900 |
| StockData Score | ||
| Total score | 1 | 17 (better) |
| Valuation score | 0 | 5 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 8.7× |
| P/S | – | 2.3× |
| P/B | – | 3.3× |
| EV/EBITDA | – | 5.8× |
| P/FCF | – | 9.0× |
| FCF yield | – | 11.2% |
| Fair value | – | $243.90 |
| Margin of safety | – | 49.5% |
| Growth | ||
| Revenue growth (TTM) | −17.7% | 17.9% (better) |
| Revenue growth, 5Y average | 2.6% | 11.4% (better) |
| EPS growth (TTM) | – | 70.7% |
| EPS growth, 5Y average | – | 43.6% |
| Profitability | ||
| Gross margin | 34.9% | 42.5% (better) |
| Operating margin | −9.8% | 41.6% (better) |
| FCF margin | 27.3% (better) | 26.2% |
| Return on invested capital | −7.4% | 37.6% (better) |
| Financial health | ||
| Debt / equity | 10.01 | 0.56 (better) |
| Net debt / EBITDA | – | 0.60 |
| Interest coverage | −0.6× | 11.1× (better) |
| Current ratio | 0.80 | 2.98 (better) |
| Altman Z-score | – | 3.38 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.7% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 10.8% |
| Buyback yield | – | 5.1% |
| Shareholder yield | – | 6.8% |
| Ownership | ||
| Held by institutions | 13.2% | 105% |
| Held by insiders | 73.3% | 0.59% |
| Insider net buying, 12 months | – | −$72.2M |
| Short interest, % of float | 2.7% | 5.9% |
Go deeper
- BIOX stock overview
- BIOX income statement
- BIOX valuation and score
- CF stock overview
- CF income statement
- CF valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.